About us

Because Quality of Life Matters

Autoimmune diseases are a complex group of conditions that occur when the immune system mistakenly attacks healthy body tissues. Standard treatments for autoimmune diseases typically involve the use of immunosuppressive drugs that are designed to reduce the activity of immune cells. However, these treatments can come with significant side effects, including an increased risk of infections and malignancies.

To overcome these limitations, we’re thinking outside the box and focussing on novel mechanisms of action to treat autoimmune disease.

Dr. Stephen Wilson

Concentrated mature researcher working at his project
0
Years Of Research
Our Focus

Novel Therapy for Immune Dysregulation

Traditionally, the treatment of autoimmune diseases has mainly focused on suppressing the immune system to prevent it from attacking the body’s own tissues. However, this approach has limitations as it can lead to increased risk of infection, and may not always be effective in treating the underlying disease. In recent years, researchers have shifted their focus to immune modulation, which aims to restore the body’s immune system to a state of balance rather than suppressing it entirely.

This approach involves using drugs that selectively inhibit or activate specific immune cells or pathways involved in autoimmune disease development. This allows for a more targeted approach to treatment that can reduce side effects and improve overall clinical outcomes. Additionally, immune modulation has the potential to provide longer-lasting disease remission compared to traditional immunosuppressive therapies.

Our vision

We’ve set out to create the next generation of therapies for immune mediated diseases.

Our mission

We are guided by an unwavering commitment to improving the lives of patients suffering from these debilitating conditions.